Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

C3_COLORECTAL_ADENO_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cancer registry: Topography ICD-O-3 — C1[8-9]\|C20 Cancer registry: Morphology ICD-O-3 — 8140 Cancer registry: Behaviour codes — 3 1 out of 7 registries used, show all original rules.	8123
4. Check minimum number of events None	8123
5. Include endpoints None	8123
6. Filter based on genotype QC (FinnGen only)	8123

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_COLORECTAL_ADENO_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C1[8-9]\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8123	3288	4835
Unadjusted period prevalence (%)	1.72	1.12	2.13
Median age at first event (years)	69.01	67.93	69.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7549: Matched controls
75469

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L01BC06

ATC

capecitabine; oral

+∞

323.0

3004

XX3DW

NOMESCO Finland

Time consuming IT work

8.6

323.0

1123

1510

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

182.0

323.0

462

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

224.0

323.0

802

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2885

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

330.6

323.0

433

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

588

JN4AD

NOMESCO Finland

Body CT examination

16.9

323.0

1578

1162

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

518.2

323.0

794

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

126.5

323.0

680

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

323.0

1427

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

323.0

342

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2008.6

323.0

769

JN4BD

NOMESCO Finland

Extensive body CT

22.5

323.0

2656

1774

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

14.2

323.0

1555

1353

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

12.9

323.0

709

601

TPH07

NOMESCO Finland

Cathetrisation of artery

5.4

323.0

1675

3773

JN4CD

NOMESCO Finland

Very extensive body CT

18.7

323.0

791

470

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

2687.8

323.0

523

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1900.2

323.0

1244

JG1BG

NOMESCO Finland

MRI of rectum

597.2

323.0

556

H02AB02

ATC

dexamethasone; systemic

95.5

323.0

1986

281

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.4

323.0

3108

10408

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

323.0

778

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

33.5

323.0

1111

386

WF049

NOMESCO Finland

Radiotherapy of metastasis

860.2

323.0

408

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

787.7

323.0

780

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

14.2

323.0

2604

2690

WX408

NOMESCO Finland

General anesthesy, balanced

4.5

323.0

3096

10100

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

6490.0

323.0

609

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

44.7

323.0

447

106

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

323.0

683

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

718

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

9998.0

323.0

1608

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

6220.5

323.0

586

C61

ICD-10 Finland

Malignant neoplasm of prostate

295.6

323.0

648

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

28.4

323.0

683

263

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

8.7

323.0

739

924

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

323.0

790

B01AB10

ATC

tinzaparin; parenteral

7.9

323.0

1019

1454

WF002

NOMESCO Finland

Radical radiotherapy

121.1

323.0

380

B01AB05

ATC

enoxaparin; parenteral

5.3

323.0

4084

13638

D75

ICPC

Malignant neoplasm colon/rectum

834.2

323.0

615

A04AA02

ATC

granisetron; systemic, transdermal

1452.3

323.0

1781

116

Kela drug reimbursment

Prostate cancer

+∞

323.0

352

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

181.4

323.0

911

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

6469.0

323.0

1129

N02AA05

ATC

oxycodone; systemic

3.8

323.0

1648

5125

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

2922

Z93.3

ICD-10 Finland

Colostomy status

99.2

323.0

518

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

323.0

407

TJF80

NOMESCO Finland

Ostomy education

91.7

323.0

513

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

323.0

634

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

5514.2

323.0

986

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

780

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

3696.8

323.0

363

Z51.5

ICD-10 Finland

Palliative care

12.7

323.0

920

815

WZC30

NOMESCO Finland

Teaching

7.6

323.0

1983

3390

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

323.0

1563

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3358.4

323.0

332

UJF32

NOMESCO Finland

Coloscopy

11.9

323.0

5251

12117

JFF23

NOMESCO Finland

Transversostomy

139.4

323.0

799

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

610

JFB30

NOMESCO Finland

Right hemicolectomy

97.7

323.0

941

110

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

323.0

768

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

323.0

347

A03FA01

ATC

metoclopramide; systemic, rectal

15.4

323.0

3609

4240

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

1126

JG1CG

NOMESCO Finland

Extensive MRI of rectum

241.4

323.0

433

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

3812

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

323.0

550

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

323.0

447

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

258.0

323.0

573

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

4989.7

323.0

479

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1915.0

323.0

348

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

323.0

543

WX302

NOMESCO Finland

Thoracal epidural anesthesy

41.9

323.0

1948

620

A04AA01

ATC

ondansetron; systemic, rectal

16.3

323.0

763

518

WX402

NOMESCO Finland

General anaesthesia

4.1

323.0

1529

4435

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

473

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

323.0

834

ZX090

NOMESCO Finland

Other technic of radiotherapy

409.0

316.5

316

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

311.5

297

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.5

304.3

569

489

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

303.1

289

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1017.4

301.8

294

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

295.6

1303

3646

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

69.4

293.5

339

A04AA55

ATC

palonosetron, combinations; systemic

2818.7

293.3

282

JFB46

NOMESCO Finland

Resection of sigmoid colon

21.0

292.7

444

224

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2808.0

292.2

281

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.5

291.9

944

1915

UJG02

NOMESCO Finland

Proctoscopy

11.8

287.5

553

503

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

287.2

274

ZX120

NOMESCO Finland

Intravenous

4.6

277.2

1065

2599

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

20.5

273.5

418

215

A04AD12

ATC

aprepitant; systemic

916.8

272.4

266

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

2573.0

269.0

259

WX600

NOMESCO Finland

Single shot through catheter

44.1

267.5

334

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

179.5

265.1

277

JFB43

NOMESCO Finland

Left hemicolectomy

44.8

262.8

327

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

662.7

261.2

257

115

Kela drug reimbursment

Breast cancer

+∞

260.8

249

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

255.6

244

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

78.3

251.7

286

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

7.8

250.7

609

835

WF003

NOMESCO Finland

Adjuvant radiotherapy

323.1

245.5

248

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

245.0

234

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

242.9

232

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

240.8

230

JFF10

NOMESCO Finland

Loop enterostomy

78.7

240.5

273

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

408.3

239.1

239

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

484.4

237.5

236

PJA12

NOMESCO Finland

Sentinel node biopsy

248.7

235.5

241

ZXC96

NOMESCO Finland

Robot assisted procedure

31.1

234.8

317

106

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

230.3

220

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

72.2

225.6

259

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.4

218.0

445

451

WF004

NOMESCO Finland

Palliative radiotherapy

731.8

217.9

214

L03AA13

ATC

pegfilgrastim; parenteral

550.7

217.2

215

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

216.6

207

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

1083.1

216.6

211

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

110.6

216.4

236

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

215.6

206

ZX095

NOMESCO Finland

Combined chemoradiotherapy

2002.5

212.2

205

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

211.5

906

2420

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.7

208.9

770

1775

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

5.5

206.7

660

1298

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

420.6

206.2

206

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

204.0

195

L01BC59

ATC

trifluridine, combinations; systemic

+∞

202.9

194

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

50.3

200.6

244

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

671.9

200.1

197

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

199.8

191

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

199.8

191

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

998.7

199.8

195

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

195.6

187

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

193.5

185

JAH00

NOMESCO Finland

Laparotomy

7.8

190.6

462

626

369

Kela drug reimbursment

Regorafenib

+∞

186.1

178

L02AE02

ATC

leuprorelin; implant, parenteral

42.8

185.8

233

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

378.3

185.4

186

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

185.1

177

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

184.0

176

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

179.8

172

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

178.8

171

176

Kela drug reimbursment

Regorafenib

+∞

178.8

171

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1857.9

178.7

173

A79

ICPC

Malignancy NOS

160.5

178.3

188

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

176.7

169

N02BE01

ATC

paracetamol; systemic, rectal

2.4

176.7

6432

53294

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

176.5

1856

9044

L03AA02

ATC

filgrastim; parenteral

66.8

174.0

202

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

172.5

165

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

171.4

164

WW500

NOMESCO Finland

Blood transfusion

7.2

170.4

433

628

1XC07

NOMESCO Finland

+∞

165.1

158

JJB10

NOMESCO Finland

Atypcal resection of liver

809.9

162.2

159

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

12.7

159.8

294

240

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.5

158.2

605

1434

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

28.4

157.9

218

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

156.7

150

SPAT1125

SPAT

Stoma care and guidance

8.6

156.3

355

432

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

151.5

145

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

148.4

142

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.3

147.0

582

1424

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

68.6

145.4

168

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7.8

144.6

348

464

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

144.2

138

JFB00

NOMESCO Finland

Partial resection of small intestine

9.5

144.2

307

334

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

143.1

834

2814

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

143.1

137

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

141.4

965

3625

Y77

ICPC

Malignant neoplasm prostate

151.8

140.8

149

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

472.8

140.7

140

L02BG04

ATC

letrozole; oral

68.8

140.3

162

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.9

140.2

617

1663

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

138.2

1400

6585

L02BB03

ATC

bicalutamide; oral

1348.3

135.8

132

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

131.6

126

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

130.8

882

3275

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

76.0

130.8

149

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

330.0

129.9

131

Z93

ICD-10 Finland

Artificial opening status

71.6

129.0

148

Z51.0

ICD-10 Finland

Radiotherapy session

417.4

124.1

124

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

124.0

1104

4827

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1217.2

123.3

120

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.9

122.8

423

894

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

185.8

122.8

128

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1196.6

121.2

118

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

119.7

3389

23669

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.2

119.0

336

561

R4110

NOMESCO Finland

Physiotherapy

2.0

116.6

1986

11609

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

115.9

111

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.6

115.4

427

972

WX306

NOMESCO Finland

Lumbar epidural anesthesy

4.3

115.2

457

1115

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

114.8

110

E0000UV

ATC

1.8

113.0

2763

18293

K56.7

ICD-10 Finland

Ileus, unspecified

7.0

113.0

291

428

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

23.6

113.0

164

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

1103.8

111.8

109

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

111.7

107

L01XE21

ATC

[U] regorafenib; oral

+∞

111.7

107

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.8

110.8

291

440

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

110.7

1007

4434

JAH01

NOMESCO Finland

Laparoscopy

5.1

110.0

369

757

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.1

109.5

454

1153

Z31.5

ICD-10 Finland

Genetic counselling

6.0

108.7

317

551

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

108.5

104

Z43.3

ICD-10 Finland

Attention to colostomy

100.7

108.2

119

A02BC02

ATC

pantoprazole; systemic

1.7

107.1

4684

36796

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1052.4

106.6

104

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.2

105.7

616

2058

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

17.6

105.7

169

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

9.2

105.3

228

255

B01AB04

ATC

dalteparin; parenteral

3.5

105.0

532

1602

HAC20

NOMESCO Finland

Total mastectomy

126.2

104.2

112

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

103.3

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

214.8

102.7

106

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

56.3

102.6

122

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

102.3

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

5.0

101.9

345

714

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

27.4

100.8

140

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

100.2

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

100.5

99.2

109

WX704

NOMESCO Finland

Intubation

3.0

97.8

612

2145

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

6.1

96.5

274

460

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

96.0

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

12.1

95.8

179

151

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.3

94.9

144

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

167.0

94.4

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

92.9

V03AF03

ATC

calcium folinate; systemic

316.5

92.0

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.7

90.1

238

363

JF2AB

NOMESCO Finland

Colongraphy with X-ray

36.8

89.9

116

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

188.1

89.4

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

26.4

89.3

125

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

88.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

88.3

671

2653

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.5

87.3

327

752

TQW40

NOMESCO Finland

Remowal of suture of skin

2.9

87.2

574

2078

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

86.6

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

11.4

86.1

165

147

JFB50

NOMESCO Finland

Other resection of colon

34.4

85.6

112

S18

ICPC

Laceration/cut

1.6

85.5

2974

21347

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

28.2

85.1

117

D99

ICPC

Disease digestive system other

9.0

85.0

185

209

SPAT1262

SPAT

Handing over of treatment supplies

1.9

84.9

1591

9449

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

84.5

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

84.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.7

84.4

119

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

14.5

83.7

144

101

L01BC53

ATC

tegafur, combinations; systemic

+∞

83.4

D18

ICPC

Change in faeces/bowel movements

5.2

82.7

267

524

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

82.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

81.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

209.6

80.4

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

79.3

L02BA01

ATC

tamoxifen; oral

76.0

79.3

R4190

NOMESCO Finland

Nutritional therapy

5.8

78.0

232

413

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

22.7

77.9

114

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.5

77.9

242

454

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

48.0

77.9

C50.99

ICD-10 Finland

Breast, unspecified

765.6

77.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.7

77.2

233

422

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.3

76.0

174

214

HA1AA

NOMESCO Finland

X-ray mammography

4.5

75.7

279

631

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

38.9

75.5

Z43.2

ICD-10 Finland

Attention to ileostomy

67.5

75.4

JJB71

NOMESCO Finland

Laparoscopic resection of liver

745.2

75.3

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

745.2

75.3

D77

ICPC

Malignant digestive neopl other/NOS

196.8

75.3

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.9

75.2

194

286

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

75.1

WX110

NOMESCO Finland

Local anesthesy

1.6

74.3

4188

33513

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

370.7

73.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.8

73.6

332

906

JFB40

NOMESCO Finland

Resection of transverse colon

45.5

73.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

72.9

466

1648

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

72.0

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

13.1

71.9

129

100

K92.1

ICD-10 Finland

Melaena

2.6

71.8

552

2189

SPAT1153

SPAT

Removal of sutures

1.6

71.0

2268

15694

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

127.8

71.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

70.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

70.6

2240

15470

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

30.7

70.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

87.6

70.0

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

350.2

69.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

69.2

907

4668

R50.9

ICD-10 Finland

Fever, unspecified

2.0

68.9

948

4976

ZZR00

NOMESCO Finland

Flap of skin

10.0

68.9

141

143

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.8

68.9

238

503

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

68.8

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.0

68.4

229

468

UJF34

NOMESCO Finland

Left colonoscopy

10.7

68.4

135

128

Z93.2

ICD-10 Finland

Ileostomy status

20.0

67.8

103

D70.82

ICD-10 Finland

Drug-induced neutropenia

20.0

67.8

103

A06AH03

ATC

naloxegol; oral

16.7

67.3

109

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.4

67.2

183

291

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.3

67.2

262

626

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.4

66.8

123

101

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

66.7

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

653.4

66.0

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

65.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

59.8

65.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.9

65.5

284

748

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.1

64.5

163

234

JAL30

NOMESCO Finland

Omentectomy

26.0

64.2

JJB30

NOMESCO Finland

Excision of two segments of liver

168.8

64.0

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

63.6

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

63.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

62.9

1287

7775

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

62.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

62.6

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

62.5

352

1142

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

314.4

62.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

214.9

62.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

61.9

2088

14545

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

612.7

61.8

TPX15

NOMESCO Finland

Removal of vascular injection port

23.1

61.4

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

77.4

61.1

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

55.8

60.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

60.5

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

60.5

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

309.9

60.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

60.1

480

1940

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

76.3

60.1

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

59.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

59.4

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

59.4

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

28.2

59.2

J01MA12

ATC

levofloxacin; systemic

1.7

59.2

1332

8275

XX1AD

NOMESCO Finland

Other CT-examination

204.8

59.1

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

126.9

58.9

6434

FHL

Anterior resection

33.8

58.8

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

582.2

58.7

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

58.5

409

1528

JFF24

NOMESCO Finland

Laparoscopic transversostomy

299.3

58.3

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

57.7

386

1405

JKA20

NOMESCO Finland

Cholecystectomy

3.2

57.6

318

1016

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

57.3

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

57.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

57.3

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

49.7

57.1

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

194.6

56.0

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

55.5

294

912

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

54.2

JFF26

NOMESCO Finland

Sigmoidostomy

42.2

53.8

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

531.4

53.6

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6.8

53.5

139

208

6404

FHL

Hemicolectomy on the right

33.6

53.5

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

272.8

53.2

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

52.9

52.8

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

521.2

52.5

C50

ICD-10 Finland

Malignant neoplasm of breast

521.2

52.5

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

11.2

52.2

100

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

51.3

558

2635

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

51.1

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

51.1

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

51.1

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

51.1

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.4

51.0

124

169

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

59.4

50.4

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

50.0

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

50.0

355

1338

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

133.3

49.8

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

11.0

49.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

49.0

550

2632

L02BX02

ATC

degarelix; parenteral

+∞

49.0

ZX050

NOMESCO Finland

Stereotactic radiotherapy

35.2

48.8

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

18.4

48.3

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

47.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

47.9

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

20.2

47.8

WX002

NOMESCO Finland

Sedation and analgesia

1.6

47.2

1373

9099

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

44.9

47.2

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

46.9

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

9.6

46.2

101

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

45.9

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

45.9

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

160.9

45.8

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.3

45.8

176

416

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

45.2

556

2763

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

44.8

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

44.8

1XC08

NOMESCO Finland

+∞

44.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

154.1

43.8

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

43.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.9

43.5

146

301

JFF13

NOMESCO Finland

Terminal enterostomy

18.2

43.0

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

19.0

43.0

UKC02

NOMESCO Finland

Cystoscopy

1.6

42.6

1175

7657

JFA42

NOMESCO Finland

Endoscopic injection in colon

11.2

42.4

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

18.0

42.2

KCC10

NOMESCO Finland

Cystoprostatectomy

216.0

41.9

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

18.2

41.7

ZX121

NOMESCO Finland

Central venous catheter

21.9

41.7

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

41.7

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.6

41.6

149

329

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

5.5

41.2

125

230

128

Kela drug reimbursment

Cancers of female genital organs

409.5

41.1

L02BG03

ATC

anastrozole; oral

90.5

40.8

KC1GB

NOMESCO Finland

Cystography with X-ray

23.3

40.4

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

13.6

40.1

X76

ICPC

Malignant neoplasm breast female

140.6

39.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

39.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

39.4

2777

22114

K65.0

ICD-10 Finland

Acute peritonitis

5.0

39.4

129

259

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

389.2

39.1

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

13.1

39.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.0

38.7

109

183

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.1

38.7

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

38.6

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

38.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

38.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

38.6

WX882

NOMESCO Finland

High dependency care

3.0

38.5

231

784

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

23.6

37.8

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

195.8

37.8

D16

ICPC

Rectal bleeding

3.5

37.5

183

534

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

37.5

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

37.5

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

34.5

37.1

JFF30

NOMESCO Finland

Other colostomy

42.0

37.1

JFB20

NOMESCO Finland

Ileocaecal resection

11.0

37.0

6435

FHL

Abdominoperineal resection and colostomy

82.5

36.8

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

130.6

36.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

36.6

1666

12160

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

36.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

36.5

J01MA02

ATC

ciprofloxacin; systemic

1.4

36.1

2612

20800

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

358.8

36.0

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.8

35.8

155

410

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

35.8

526

2802

P01AB01

ATC

metronidazole; oral, rectal

1.4

35.7

2268

17646

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

35.4

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

35.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

35.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

35.4

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.5

35.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

5.3

35.1

110

211

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

180.7

34.7

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

10.5

34.7

A06AD11

ATC

lactulose; oral

1.6

34.5

1128

7635

N03AX16

ATC

pregabalin; oral

1.5

34.5

1478

10636

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

34.4

C209

ICD-10 Finland

+∞

34.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

34.3

300

1271

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

33.9

276

1126

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

338.5

33.9

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.4

33.9

126

290

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

120.5

33.7

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

120.5

33.7

R11

ICD-10 Finland

Nausea and vomiting

1.9

33.4

495

2643

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

33.3

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

33.3

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

33.3

L01BC04

ATC

carmofur; oral

+∞

33.3

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

33.3

JEA00

NOMESCO Finland

Appendectomy

2.2

33.1

338

1545

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.2

33.1

149

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

12.3

33.1

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.1

33.1

186

605

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.4

33.0

101

189

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

328.3

32.9

JN4DD

NOMESCO Finland

Scout CT scan of torso

74.4

32.8

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

13.0

32.7

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

44.6

32.7

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

8.7

32.7

ZX112

NOMESCO Finland

Subcutaneous

6.0

32.6

152

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

15.1

32.5

XKD00

NOMESCO Finland

Uroflowmetry

1.5

32.3

1121

7685

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

32.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

32.3

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

18.0

32.2

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

18.0

32.2

TJG20

NOMESCO Finland

Transanal irrigation

15.2

32.0

G04BE03

ATC

sildenafil; oral

8.2

31.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

31.6

161

487

K56.0

ICD-10 Finland

Paralytic ileus

4.4

31.5

118

274

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

31.5

456

2414

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

31.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

31.3

JFC10

NOMESCO Finland

Ileotransversostomy

53.0

31.3

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.9

31.2

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

60.2

31.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

30.9

626

3712

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

70.1

30.8

JJA20

NOMESCO Finland

Open biopsy of liver

20.1

30.8

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

110.4

30.6

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.7

30.5

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

22.1

30.4

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

19.3

30.4

ZX100

NOMESCO Finland

Oral

4.3

30.3

115

271

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

30.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

30.2

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

11.2

30.2

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

303.4

29.8

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

155.5

29.7

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.4

29.6

110

254

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.6

29.3

228

909

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

50.2

29.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

292.8

28.8

LEC00

NOMESCO Finland

Partial excision of vagina

80.4

28.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

103.7

28.6

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

103.7

28.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

14.6

28.6

L02BB04

ATC

enzalutamide; oral

+∞

28.1

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

28.1

L01EX05

ATC

regorafenib; oral

+∞

28.1

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

28.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

28.1

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

77.9

27.7

SPAT1131

SPAT

Colonoscopy

2.3

27.5

260

1146

KCD10

NOMESCO Finland

Partial cystectomy

47.3

27.4

R18

ICD-10 Finland

Ascites

3.7

27.4

124

343

B80

ICPC

Iron deficiency anaemia

3.2

27.3

148

470

GDC00

NOMESCO Finland

Lobectomy of lung

19.6

27.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

27.2

871

5843

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

27.1

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

+∞

27.1

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

27.1

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

27.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

27.1

253

1111

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

31.9

26.8

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

271.8

26.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

271.8

26.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

26.7

1034

7238

S77

ICPC

Malignant neoplasm of skin

15.4

26.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

26.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

26.0

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

12.8

26.0

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

21.2

26.0

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

31.0

25.9

WX892

NOMESCO Finland

Monitored bed care

1.7

25.8

513

3023

XQ902

NOMESCO Finland

Other photography

7.6

25.6

LCD00

NOMESCO Finland

Hysterectomy

2.4

25.5

221

934

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.8

25.3

108

285

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

25.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

25.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

25.0

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

25.0

JFA70

NOMESCO Finland

Suture of small intestine

12.2

24.9

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

24.9

155

541

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.5

24.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

26.2

24.8

JAD10

NOMESCO Finland

Repair of incisional hernia

4.8

24.7

178

GDB10

NOMESCO Finland

Wedge resection of lung

19.5

24.7

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

21.3

24.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

130.3

24.6

KAC10

NOMESCO Finland

Total nephrectomy with capsule

24.4

24.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

48.4

24.2

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

24.0

226

995

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.7

24.0

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

24.0

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

24.0

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

24.0

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

24.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

24.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

23.8

366

1981

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

240.5

23.6

KFC10

NOMESCO Finland

Bilateral orchiectomy

125.3

23.6

L02AE04

ATC

triptorelin; parenteral

41.5

23.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

23.6

962

6796

R03AC02

ATC

salbutamol; inhalant

0.8

23.6

2237

26714

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

23.5

236

1072

3AC01

NOMESCO Finland

4.0

23.4

235

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

23.4

302

1530

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

19.5

23.4

Z71.8

ICD-10 Finland

Other specified counselling

1.4

23.3

1234

9168

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

46.8

23.3

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

54.1

23.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

23.0

202

860

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

22.9

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

22.9

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

9.1

22.9

JFH10

NOMESCO Finland

Total colectomy and ileostomy

11.7

22.9

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

65.1

22.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

22.7

667

4371

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

10.0

22.7

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.2

22.7

121

382

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

120.3

22.6

ZXC40

NOMESCO Finland

Use of ultrasound

6.9

22.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

22.5

115

352

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.8

22.2

154

WGA11

NOMESCO Finland

Planning of pain management

19.5

22.1

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

22.0

246

1174

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

21.9

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

21.9

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

21.9

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

21.9

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

21.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

21.9

JN6AD

NOMESCO Finland

CT of torso and neck

6.6

21.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

21.8

1332

16911

A28

ICPC

Limited function/disability NOS

1.4

21.7

1140

8452

C90.0

ICD-10 Finland

Multiple myeloma

220.4

21.6

K62.7

ICD-10 Finland

Radiation proctitis

220.4

21.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

220.4

21.6

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

115.3

21.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

21.5

1093

14261

J01DB01

ATC

cefalexin; oral

1.3

21.5

5136

47087

L02AE03

ATC

goserelin; implant

11.9

21.4

D28

ICPC

Limited function/disability (D)

7.8

21.4

G04CA02

ATC

tamsulosin; oral

1.3

21.4

1896

15299

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

21.2

450

2699

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

13.9

21.2

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.3

21.1

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.4

20.9

118

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

60.1

20.8

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.8

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

20.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.8

20.8

136

492

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

76.9

20.7

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

11.6

20.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

20.6

859

11568

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

210.4

20.6

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

110.2

20.6

JFC20

NOMESCO Finland

Other enterocolostomy

30.1

20.5

SPAT1255

SPAT

Intravenous administration of medicine

1.7

20.4

413

2444

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

8.0

20.4

N05AX08

ATC

risperidone; systemic

0.5

20.4

217

3909

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

48.1

20.1

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

19.8

115

386

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

19.8

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

19.8

L02BX03

ATC

abiraterone; oral

+∞

19.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

19.8

NET99

NOMESCO Finland

Other operation on pelvis

105.2

19.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

200.3

19.5

K83.1

ICD-10 Finland

Obstruction of bile duct

3.9

19.5

205

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

8.6

19.5

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

19.3

418

2523

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

19.3

226

1104

L57.0

ICD-10 Finland

Actinic keratosis

1.6

19.2

510

3258

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.5

19.2

105

DAB10

NOMESCO Finland

Partial excision of auricle

46.1

19.2

KA1FN

NOMESCO Finland

Isotope renography

6.6

19.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

18.8

554

3632

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

18.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

18.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

18.7

1XA03

NOMESCO Finland

+∞

18.7

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

18.7

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

18.7

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

18.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

18.7

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

18.7

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

18.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

18.6

860

6210

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.3

18.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

190.3

18.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

190.3

18.5

JFH96

NOMESCO Finland

Other total colectomy

38.4

18.5

A07DA03

ATC

loperamide; oral

2.0

18.5

238

1207

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

17.5

18.2

TJA10

NOMESCO Finland

Laparocentesis

17.5

18.2

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

7.9

18.2

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.8

18.1

1228

15430

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.4

18.0

252

QX9VV

NOMESCO Finland

52.6

17.9

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

18.0

17.7

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

+∞

17.7

L02BG06

ATC

exemestane; oral

+∞

17.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

17.7

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

17.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

17.7

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

17.7

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

17.7

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

+∞

17.7

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

17.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

17.7

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

66.7

17.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

17.7

1159

14641

R33

ICD-10 Finland

Retention of urine

1.5

17.6

588

3969

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

95.2

17.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

95.2

17.5

KA3EB

NOMESCO Finland

Antegrade pyelography

7.7

17.5

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.4

17.3

141

B82

ICPC

Anaemia other/unspecified

2.2

17.3

170

769

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.9

17.2

179

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

17.2

223

1133

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.5

17.2

133

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

4.0

17.2

175

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

17.1

327

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

7.7

17.0

KBH20

NOMESCO Finland

Replantation of ureter

15.9

17.0

D29

ICPC

Digestive symptom/complaint other

2.6

16.9

121

464

LAE10

NOMESCO Finland

Unilateral oophorectomy

8.2

16.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

16.8

627

4335

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

63.4

16.7

D74

ICPC

Malignant neoplasm stomach

63.4

16.7

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

11.1

16.7

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

16.7

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

16.7

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

16.7

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

16.7

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

16.7

JFB96

NOMESCO Finland

Other partial excision of intestine

35.1

16.6

M25.5

ICD-10 Finland

Pain in joint

0.7

16.6

920

11911

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

90.2

16.5

A21

ICPC

Risk factor for malignancy

170.2

16.5

WGA10

NOMESCO Finland

Measurement of pain intensity

170.2

16.5

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

17.9

16.4

RD211

NOMESCO Finland

1.9

16.4

246

1323

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

16.4

853

6291

TQW20

NOMESCO Finland

Tatoe

20.0

16.4

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

16.3

233

1231

UJF32

SPAT

2.8

16.2

104

374

D07AA02

ATC

hydrocortisone; topical

1.5

16.2

679

4810

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

16.0

126

509

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.0

16.0

308

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

11.6

16.0

UJK02

NOMESCO Finland

ERCP

2.2

15.9

158

718

WW200

SPAT

0.6

15.9

227

3790

ZZR10

NOMESCO Finland

Flap of skin and muscle

9.4

15.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

15.7

218

1138

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.6

15.7

200

JHA00

NOMESCO Finland

Anal or perianal incision

3.3

15.7

237

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

15.6

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

15.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

15.6

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

15.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

15.6

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

15.6

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

15.6

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

+∞

15.6

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

15.6

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

15.6

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

15.6

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

15.6

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

15.6

C18.89

ICD-10 Finland

Malignant overall tumor of the colon other or unspecified histology

+∞

15.6

SPAT1088

SPAT

Blood transfusion

6.2

15.5

K63.5

ICD-10 Finland

Polyp of colon

2.9

15.5

316

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

15.4

982

7491

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

8.5

15.4

D50

ICD-10 Finland

Iron deficiency anaemia

2.8

15.3

100

366

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

16.0

15.2

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

16.0

15.2

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

20.0

15.1

JFW98

NOMESCO Finland

Other transluminal endoscopic operation on intestine

45.0

15.0

GDB20

NOMESCO Finland

Segmental resection of lung

45.0

15.0

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

45.0

15.0

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.6

15.0

192

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.2

15.0

251

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

14.8

1349

16407

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

14.8

128

545

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.3

14.7

222

D64.8

ICD-10 Finland

Other specified anaemias

2.6

14.7

109

430

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

18.4

14.6

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.8

14.6

335

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

14.6

L01CA04

ATC

vinorelbine; systemic

+∞

14.6

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

14.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

14.6

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

14.6

1CD02

NOMESCO Finland

+∞

14.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

14.6

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.7

14.5

100

377

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

14.5

370

2340

JFC00

NOMESCO Finland

Entero-enterostomy

14.1

14.5

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

150.2

14.5

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

150.2

14.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

150.2

14.5

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

150.2

14.5

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

14.4

313

K62.1

ICD-10 Finland

Rectal polyp

3.0

14.3

273

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

5.1

14.3

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

17.0

14.3

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

11.3

14.2

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

6.3

14.2

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

19.1

14.2

WX610

NOMESCO Finland

Patient controlled analgesia

6.1

14.2

M01AC06

ATC

meloxicam; systemic, rectal

0.8

14.1

1583

18816

KBV10

NOMESCO Finland

Removal of stent from ureter

4.2

14.1

123

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.6

14.1

K61.1

ICD-10 Finland

Rectal abscess

7.0

14.0

WX250

NOMESCO Finland

Intercostal blockade

11.9

14.0

WX290

NOMESCO Finland

Other blockade of nerve

1.2

14.0

1887

15909

R19.4

ICD-10 Finland

Change in bowel habit

2.2

14.0

145

676

SPAT1078

SPAT

Removal of central venous or arterial cannula

10.9

14.0

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.9

13.9

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

8.8

13.9

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

10.0

13.9

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

9.4

13.9

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.0

13.9

D17

ICPC

Incontinence of bowel

3.4

13.8

190

UJH02

NOMESCO Finland

Anoscopy

1.8

13.8

230

1285

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

17.5

13.8

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

53.4

13.8

R01AD09

ATC

mometasone; nasal

0.8

13.8

1664

19637

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.7

13.8

160

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

23.8

13.8

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

11.4

13.7

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3593

19903

2.44

323.31

2.8

2.3

u/l

55.5

60.7

6.30

3429

18163

(3023368) Bacteria identified in Blood by Culture

3502

18474

2.57

307.65

5.0

4.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5700

30662

3.88

307.65

14.8

3.8

umol/l

11.6

12.4

4.67

5566

28611

(3044640) Blood type and Crossmatch panel - Blood

4015

17922

3.45

307.65

3.4

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1781

1293

17.36

307.65

6.1

1.8

u/ml

1435.2

73.9

2.31

1609

1046

(3024561) Albumin [Mass/volume] in Serum or Plasma

5185

27245

3.50

307.65

10.4

3.8

g/l

33.2

35.1

97.00

5000

24766

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3248

13714

3.28

307.65

3.1

2.2

—

(40768804) Tissue Pathology biopsy report

4070

18725

3.35

307.65

2.8

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1818

6259

3.45

307.65

3.0

2.2

umol/l

9.0

8.4

0.38

1675

5368

(3033658) Prothrombin time (PT) actual/Normal

3022

14724

2.67

307.65

5.4

3.6

87.9

84.2

12.19

2992

14341

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

955

763

14.05

307.65

5.5

1.9

u/ml

161.4

426.4

0.63

869

685

(3002256) Pathology report gross observation

1456

4613

3.63

307.65

1.4

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5216

32636

2.67

307.65

16.5

6.1

e9/l

3.9

4.4

46.59

4747

27711

(4035726)

1750

1743

12.52

307.65

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2024

4739

5.35

307.65

2.5

2.0

g/l

0.2

2.76

1957

4275

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6073

3613

63.62

307.65

9.7

1.4

ug/l

33.1

7.3

4.19

5602

2720

(3032080) INR in Blood by Coagulation assay

4717

28096

2.62

307.65

9.5

11.2

inr

1.2

1.4

10.18

1245

7622

(3022145) Colonoscopy Study observation

3050

6093

7.41

307.65

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5187

26686

3.61

307.65

5.6

3.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1440

5132

3.19

307.44

2.4

2.2

u/l

35.0

48.5

0.75

1329

4318

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6419

47376

2.69

287.72

16.1

5.4

u/l

91.9

76.9

52.62

6226

43604

(3037121) Protein [Mass/volume] in Urine

831

2146

4.20

287.68

6.3

2.5

g/l

0.2

0.3

11.06

643

749

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

377

479

8.20

278.01

2.1

1.8

u/ml

254.7

330.6

0.09

371

467

(3014576) Chloride [Moles/volume] in Serum or Plasma

1872

8346

2.61

259.38

9.2

6.4

mmol/l

105.1

104.3

11.62

1841

8121

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1929

9186

2.44

228.93

2.2

2.7

18.5

22.1

23.56

1693

7610

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1961

9480

2.41

224.52

5.3

2.5

mmol/l

0.8

22.94

1874

8602

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2007

9813

2.39

223.89

2.2

2.6

g/l

2.4

2.3

20.41

1909

8959

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2291

11926

2.28

220.30

9.6

2.2

mmol/l

2.5

20.66

2146

10142

(3015377) Calcium [Moles/volume] in Serum or Plasma

3361

20353

2.11

220.21

8.2

2.1

mmol/l

2.3

2.4

1.10

3063

16742

(3022948) Iron [Moles/volume] in Serum or Plasma

2098

10688

2.30

211.09

2.3

2.6

umol/l

10.9

12.5

16.46

1984

9726

(3013826) Glucose [Moles/volume] in Serum or Plasma

5257

38313

2.05

198.76

6.0

4.5

mmol/l

6.9

0.44

5074

35809

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1151

4587

2.76

194.94

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2914

17346

2.06

193.95

2.3

mg/l

4.0

3.0

40.88

2518

14608

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3001

18122

2.04

191.41

4.7

2.6

u/l

37.5

35.6

0.22

2897

16938

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4302

29734

1.95

183.01

7.2

5.4

mmol/l

1.2

20.61

3989

26191

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4629

32871

1.95

180.76

8.2

5.8

mmol/l

1.2

29.73

3926

27403

(40758558) Short blood count panel - Blood

2420

13783

2.08

178.80

13.0

4.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

140

18.48

175.60

2.2

1.1

u/ml

18.7

17.0

0.38

135

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

701

2248

3.32

173.71

2.6

3.0

u/ml

0.3

1.91

407

1329

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

917

3486

2.84

168.69

8.8

9.8

—

(3003694) ABO and Rh group [Type] in Blood

2416

14015

2.03

167.82

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1365

6464

2.34

158.12

8.1

7.6

g/l

115.9

122.4

28.60

1327

6220

(3016502) Oxygen saturation in Arterial blood

1451

7243

2.22

147.26

7.8

7.1

96.7

95.1

20.64

1409

6959

(3003396) Base excess in Arterial blood by calculation

1546

7989

2.15

143.45

7.5

6.8

mmol/l

0.8

1.3

3.91

1255

6169

(3027801) Oxygen [Partial pressure] in Arterial blood

1543

8014

2.14

141.07

7.5

6.8

kpa

13.9

11.4

50.41

1486

7595

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1543

8020

2.14

140.77

7.5

6.8

kpa

5.1

5.0

3.81

1489

7614

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3512

24350

1.78

132.49

2.9

ug/l

138.3

143.8

0.34

3217

22035

(3014111) Lactate [Moles/volume] in Serum or Plasma

1207

5860

2.24

129.80

6.1

6.5

mmol/l

1.3

1.4

3.43

1152

5628

(3002582) Erythrocytes [#/volume] in Urine

2942

19638

1.78

124.28

3.6

3.1

e6/l

80.2

115.1

0.81

2407

14980

(3031040) Bacteria [#/volume] in Urine by Automated count

5282

41799

1.75

119.45

5.0

4.6

e6/l

1996.1

1767.5

0.07

708

(3042936) Bacteria identified in Isolate by Culture

1582

8804

1.99

117.60

2.2

2.1

—

(40768441) Liver Pathology biopsy report

158

214

7.51

109.90

1.1

1.3

—

(36304419) Bacteria [Presence] in Urine

2589

17149

1.75

109.03

3.5

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

2681

17971

1.73

107.98

3.5

3.0

e6/l

0.5

0.35

2161

13430

(3020779) Urea [Moles/volume] in Serum or Plasma

1182

6092

2.10

107.75

5.4

6.8

mmol/l

9.6

11.5

13.59

1126

5710

(3026782) Osmolality of Urine

2043

12674

1.82

107.40

3.1

2.7

mosm/kgh2o

539.9

552.3

1.81

1812

10586

(3014007) Fractional oxyhemoglobin in Arterial blood

896

4178

2.29

104.86

8.5

8.7

94.9

93.4

11.58

896

4162

(3000991) Gas panel - Venous blood

1069

5526

2.08

95.92

7.2

7.8

—

(42870588) Differential panel, method unspecified - Blood

2876

20217

1.65

93.67

4.4

5.2

—

(3006504) Eosinophils/100 leukocytes in Blood

3662

27433

1.61

91.50

4.7

5.5

2.7

3.0

8.63

3405

25083

(3019069) Monocytes/100 leukocytes in Blood

3676

27576

1.61

91.23

4.9

5.8

9.0

8.9

1.91

3421

25323

(3018095) Leukocytes [#/volume] in Urine

3134

22619

1.63

91.21

4.2

3.6

e6/l

139.4

119.4

0.60

2495

16065

(3000850) Epithelial cells [#/volume] in Urine

2104

13721

1.72

90.46

2.8

2.5

e6/l

5.2

4.6

0.99

1879

11840

(3002030) Lymphocytes/100 leukocytes in Blood

3724

28131

1.60

88.99

4.9

5.7

23.3

26.4

48.55

3439

25660

(3022096) Basophils/100 leukocytes in Blood

3565

26655

1.60

88.95

4.7

5.5

0.6

0.7

19.82

3310

24417

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

504

1995

2.63

83.91

1.3

1.2

—

(3026008) Bacteria identified in Urine by Culture

2816

20185

1.60

81.97

3.4

3.3

—

(3018010) Neutrophils/100 leukocytes in Blood

3639

27819

1.56

79.35

4.7

5.5

60.7

58.5

20.66

3387

25541

(3018418) pH of Serum or Plasma

2673

19051

1.60

78.99

4.9

3.4

7.4

1.35

570

3330

(3006315) Basophils [#/volume] in Blood

3827

29727

1.54

76.71

4.5

5.2

e9/l

0.0

13.42

3265

25217

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

716

3459

2.17

75.81

8.6

8.9

mmol/l

24.0

24.4

3.85

690

3136

(3001604) Monocytes [#/volume] in Blood

3794

29512

1.54

74.91

4.5

5.2

e9/l

0.6

0.18

3227

24991

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

605

2769

2.28

73.05

1.9

1.8

ug/l

2.0

0.02

544

2383

(3019198) Lymphocytes [#/volume] in Blood

3863

30285

1.52

72.75

4.6

5.3

e9/l

1.7

1.8

0.90

3352

26122

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1156

6708

1.84

72.38

3.0

2.7

u/l

250.1

244.6

0.50

1099

6191

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

389

1466

2.74

71.22

2.6

1.5

u/ml

62.4

28.6

2.60

378

1381

(3013115) Eosinophils [#/volume] in Blood

3896

30686

1.52

71.20

4.6

5.4

e9/l

0.2

10.27

3375

26389

(3027945) Reticulocytes/100 erythrocytes in Blood

1334

8119

1.77

71.13

2.0

2.1

1.8

0.73

1176

7005

(3018572) Chloride [Moles/volume] in Blood

398

1547

2.65

68.55

8.1

6.8

mmol/l

106.3

104.8

9.82

364

1399

(3039000) Anion gap in Blood

398

1547

2.65

68.55

8.1

6.7

mmol/l

11.1

11.3

1.16

364

1399

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1580

10215

1.68

67.27

3.3

2.8

e6/l

2.8

2.3

1.26

947

5563

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1356

8415

1.73

67.16

4.5

5.4

mmol/l

1.0

0.70

1261

7666

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6810

61228

1.69

64.06

28.8

14.7

mg/l

37.2

25.4

118.28

6333

48815

(3037467) Urinalysis macro (dipstick) panel - Urine

5158

43563

1.50

64.00

5.5

4.4

—

(3019060) Gas panel - Arterial blood

884

4965

1.88

60.73

6.0

4.6

—

(3047181) Lactate [Moles/volume] in Blood

481

2176

2.29

59.46

7.3

6.0

mmol/l

1.4

1.3

0.58

433

1945

(3008152) Bicarbonate [Moles/volume] in Arterial blood

840

4696

1.88

58.44

8.2

6.8

mmol/l

24.5

24.6

0.36

799

4370

(3025941) Bacteria identified in Stool by Culture

600

3043

2.05

55.37

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1660

11379

1.58

54.24

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4357

36421

1.42

51.09

3.8

3.0

u/l

70.5

50.7

17.25

4076

32970

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1062

6658

1.68

49.40

4.9

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

337

1421

2.43

48.82

2.1

2.4

g/l

3.7

3.6

0.23

331

1343

(3023520) Reticulocytes [#/volume] in Blood

987

6088

1.71

48.74

2.1

2.2

e9/l

69.8

68.4

0.51

764

4654

(40768800) Prostate Pathology biopsy report

173

513

3.42

48.06

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

578

3057

1.96

47.20

6.5

4.9

0.9

2.23

540

2881

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

221

771

2.92

46.72

1.2

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

582

3099

1.95

46.58

6.4

4.9

1.6

0.27

545

2925

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1596

11195

1.53

46.05

3.2

2.6

e6/l

1.2

0.01

951

6477

(40768793) Breast Pathology biopsy report

118

276

4.32

45.92

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1502

10427

1.54

45.38

2.0

1.9

30.1

0.04

1467

10096

(4281824)

118

283

4.21

44.46

1.2

—

(40768795) Lymph node Pathology biopsy report

122

6.11

42.88

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

297

1321

2.29

38.10

1.3

—

(3019225) pH of Specimen

1026

6817

1.58

37.01

4.7

3.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

127

378

3.40

35.16

1.7

1.3

ug/l

19.4

19.8

0.05

122

364

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

184

686

2.72

34.41

1.1

g/l

1.6

1.5

1.40

174

602

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

116

335

3.50

33.67

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

355

1782

2.04

33.49

1.8

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

287

1333

2.19

33.17

2.1

2.4

221.5

196.9

4.62

274

1259

(40762365) Oxygen content in Arterial blood by calculation

101

5.87

32.95

3.3

2.7

ml/dl

13.7

15.2

3.50

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

302

1439

2.14

32.73

2.0

2.1

84.4

89.2

2.82

293

1344

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

197

780

2.56

32.69

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

752

2.59

32.57

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

206

835

2.50

32.54

5.8

6.4

mg/l

11.9

12.4

0.75

186

750

(3025468) Yersinia sp identified in Specimen by Organism specific culture

190

743

2.59

32.34

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

744

2.58

31.74

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

758

2.56

31.55

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

189

747

2.57

31.49

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

70.13

30.85

1.1

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

988

6820

1.51

29.54

3.0

3.7

kpa

5.6

5.9

8.40

957

6604

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

644

4030

1.65

29.46

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

489

2844

1.76

29.30

1.9

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

626

3917

1.65

28.63

2.5

—

(3002032) Base excess in Venous blood by calculation

982

6819

1.50

28.47

3.0

3.7

mmol/l

1.8

1.9

0.29

760

5532

(3019550) Sodium [Moles/volume] in Serum or Plasma

6943

65249

1.44

28.19

34.5

18.0

mmol/l

139.3

139.7

45.96

6829

63366

(3021589) Normoblasts [#/volume] in Blood

3115

26216

1.30

27.81

15.4

9.0

e9/l

0.0

0.19

2545

21348

(3051651) Icteric interference index of Serum or Plasma

106

328

3.26

27.66

5.3

4.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

6949

65388

1.43

27.33

34.6

18.2

mmol/l

4.0

22.30

6831

63410

(40761511) CBC panel - Blood by Automated count

6726

62944

1.40

27.19

29.2

14.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.16

27.01

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6221

57577

1.34

26.41

29.7

13.6

ml/min/173m2

76.0

73.5

19.52

5629

46475

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

16.96

26.32

1.1

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1036

7378

1.46

26.32

1.8

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

448

2631

1.74

25.92

1.9

1.7

—

(40768797) Stomach Pathology biopsy report

1167

8573

1.42

24.98

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

776

5300

1.51

24.18

4.7

3.1

mmol/l

1.2

1.67

701

4458

(3013512) EKG study

2491

20642

1.30

24.04

4.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

515

3212

1.64

23.78

2.7

4.0

mmol/l

23.8

24.2

1.19

471

2844

(3004809) Band form neutrophils/100 leukocytes in Blood

179

789

2.30

23.56

2.4

2.9

2.4

1.2

2.50

141

582

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

530

3344

1.63

23.37

1.5

g/l

1.7

1.5

4.64

455

2841

(3023183) Ammonium ion [Moles/volume] in Plasma

257

1310

1.99

23.28

2.1

2.5

umol/l

32.1

33.7

0.48

215

1103

(3018405) Lactate [Moles/volume] in Arterial blood

435

2628

1.69

22.70

4.7

3.9

mmol/l

1.3

1.4

1.11

429

2572

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.19

22.61

1.8

2.2

—

(3044889) 12 lead EKG panel

4986

45178

1.27

22.54

4.5

4.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

307

1687

1.85

22.21

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

309

1704

1.84

22.10

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

308

1712

1.83

21.48

1.1

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

638

4290

1.53

21.32

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

267

1428

1.90

21.03

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1070

7965

1.39

20.96

1.7

—

(3012501) Base excess in Blood by calculation

279

1523

1.86

20.63

4.5

4.2

mmol/l

2.7

2.6

0.17

200

1016

(3033799) Differential panel - Peritoneal fluid

151

3.93

20.55

1.8

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

338

1963

1.75

20.35

4.9

3.6

—

(3010421) pH of Blood

311

1768

1.79

20.15

4.4

4.1

7.4

0.20

275

1481

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

730

5123

1.47

19.75

4.3

2.5

ml/min/173m2

61.6

60.6

0.30

323

2058

(3020891) Body temperature

465

2967

1.60

19.56

5.2

4.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6862

65159

1.34

19.40

19.2

9.5

u/l

24.5

25.3

3.09

6707

61990

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

708

9880

0.69

19.27

1.2

1.3

iu/ml

54.3

38.8

1.40

229

3050

(3017181) Myelocytes/100 leukocytes in Blood

684

4776

1.47

18.98

3.2

3.6

1.1

0.8

1.53

265

1070

(40761536) Microorganisms panel - Urine sediment

699

4926

1.46

18.48

4.5

4.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

666

9326

0.69

18.41

1.2

u/ml

19.3

15.2

0.49

241

3322

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1051

7962

1.37

18.33

1.7

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

5686

52832

1.25

18.30

31.1

16.3

37.1

39.1

34.48

3563

32981

(3049717) Cytology report of Urine Cyto stain

386

2395

1.64

18.19

2.9

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

148

677

2.21

17.93

4.7

3.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5689

60513

0.80

17.82

4.3

4.8

mmol/l

1.4

0.10

5045

54811

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

17.71

1.0

0.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5751

61073

0.80

17.56

4.3

4.9

mmol/l

4.5

0.03

5148

55752

(3036489) Thrombin time

331

1992

1.69

17.55

1.9

21.5

21.6

0.06

312

1755

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

106

426

2.51

17.25

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

6.19

17.16

6.0

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

651

4591

1.45

17.12

3.1

3.6

0.2

0.1

1.53

246

995

(3022217) INR in Platelet poor plasma by Coagulation assay

1360

10839

1.31

16.64

23.9

30.5

inr

1.4

1.5

3.46

218

1451

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

103

418

2.48

16.44

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5592

59435

0.81

16.32

6.4

6.7

mmol/mol

41.3

41.0

1.10

5006

54246

(3048689) Calprotectin [Mass/mass] in Stool

817

6051

1.39

16.29

1.6

2.1

ug/g

270.6

157.9

7.34

632

4686

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

2.75

16.13

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

2.75

16.13

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

620

4384

1.45

16.06

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

247

1414

1.77

15.70

1.2

titre

59.3

175.3

1.76

116

(3024354) Oxygen [Partial pressure] in Venous blood

770

5681

1.39

15.69

2.7

3.1

kpa

4.6

4.4

0.77

740

5473

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1392

17062

0.78

15.66

1.6

mmol/l

1.4

1.3

2.94

1142

14019

(3002179) Metamyelocytes/100 leukocytes in Blood

615

4372

1.44

15.48

3.0

3.5

0.7

0.6

1.34

179

797

(1616796) Gas panel - Central venous blood

261

1535

1.72

15.11

3.8

3.7

—

(3002385) Erythrocyte distribution width [Ratio]

5239

48658

1.21

14.98

37.9

17.5

14.7

13.8

212.54

5173

47351

(3004716) Salmonella sp identified in Stool by Organism specific culture

348

2222

1.59

14.63

1.2

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

189

1020

1.87

14.59

3.5

3.3

58.4

59.0

0.23

189

1020

(3034770) Mitochondria Ab [Titer] in Serum

244

1424

1.73

14.53

1.2

titre

401.7

1078.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1450

11843

1.27

14.45

4.0

4.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1833

15434

1.24

13.97

1.8

nmol/l

1190.9

1157.4

0.73

1394

11497

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

230

1338

1.74

13.87

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1695

14166

1.25

13.79

3.7

4.2

ng/l

475.4

574.4

0.25

1437

12067

(3017143) Hepatitis C virus Ab [Presence] in Serum

580

4189

1.41

13.36

1.3

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5970

62680

0.82

13.24

4.8

5.5

mmol/l

2.6

0.61

5303

57006

(3024731) MCV [Entitic volume]

6993

67256

1.28

13.10

44.5

21.4

91.2

91.7

10.82

6905

65846

(3007461) Platelets [#/volume] in Blood

6991

67238

1.28

13.07

44.7

21.5

e9/l

248.8

239.9

20.11

6861

64927

(3026361) Erythrocytes [#/volume] in Blood

6993

67262

1.28

13.05

44.7

21.5

e12/l

4.3

4.5

201.40

6849

64652

(3035941) MCH [Entitic mass]

6992

67255

1.28

13.02

44.5

21.4

30.1

30.5

54.40

6902

65845

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3119

27828

1.20

13.00

3.9

4.1

ng/l

41.7

95.9

3.47

2530

20955

(3000963) Hemoglobin [Mass/volume] in Blood

6993

67269

1.28

12.99

45.0

21.6

g/l

126.7

135.4

307.65

6903

65867

(3010813) Leukocytes [#/volume] in Blood

6992

67272

1.28

12.87

44.7

21.5

e9/l

6.9

6.8

1.15

6855

64669

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5548

58559

0.83

12.45

3.9

4.3

mmol/l

1.3

2.26

4882

52544

(3025159) Blasts/100 leukocytes in Blood

593

4358

1.39

12.33

3.2

3.7

0.3

0.07

198

868

(3012441) Differential panel - Pleural fluid

128

642

2.01

12.33

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1288

1.70

12.22

1.3

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

172

955

1.82

12.21

1.3

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

237

1446

1.66

12.04

2.5

15.4

16.3

2.33

118

782

(3043409) Potassium [Moles/volume] in Arterial blood

340

2263

1.52

11.94

5.2

4.2

mmol/l

3.8

3.9

6.88

322

2126

(3003434) Protein [Mass/volume] in Pleural fluid

155

840

1.86

11.90

1.3

1.5

g/l

30.8

28.8

1.07

140

728

(3013707) Erythrocyte sedimentation rate by Westergren method

4992

46637

1.18

11.55

3.6

4.2

mm/h

17.7

13.2

49.09

4505

42640

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

241

2.63

11.48

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

241

2.63

11.48

1.4

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

241

2.63

11.48

1.4

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

241

2.58

10.96

1.5

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

179

2.86

10.96

2.8

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

174

2.88

10.91

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

110

548

2.02

10.86

1.2

1.3

u/l

293.0

296.5

0.03

102

511

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

603

1.97

10.84

2.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

6.55

10.62

1.1

1.0

ug/l

2.6

1.4

—

(40768806) Pleura Pathology biopsy report

117

601

1.96

10.60

1.4

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

495

3628

1.39

10.48

3.3

2.6

e6/l

0.3

0.19

488

3553

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

173

2.84

10.44

1.5

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

173

2.84

10.44

1.5

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

180

2.79

10.28

1.5

2.5

e6/l

11921.3

602.6

0.50

129

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

312

2.32

10.11

2.2

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

134

3.07

10.01

1.9

3.1

58.4

58.1

0.03

125

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

156

2.89

9.92

1.5

2.3

e6/l

19412.9

23644.7

0.09

(40761539) Cells [Type] in Urine sediment by Light microscopy

136

3.02

9.77

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

136

755

1.81

9.75

1.4

1.5

e6/l

1032.6

2655.3

2.27

103

546

(3043410) Blood group antigens tested for on Red Blood Cells

166

2.78

9.45

2.0

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

571

4353

1.33

9.41

3.3

3.5

mmol/l

1.9

0.07

414

3180

(3000494) Fungus identified in Specimen by Culture

866

6981

1.27

9.37

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.50

9.28

2.3

2.4

62.0

66.5

0.21

(3037522) Nuclear Ab [Titer] in Serum

591

7603

0.76

9.23

1.2

1.3

titre

484.6

523.3

0.21

130

1688

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

681

1.83

9.23

1.4

1.5

e6/l

128914.5

67360.1

0.48

395

(3009343) pH of Capillary blood

585

4502

1.32

9.03

3.3

3.5

7.4

0.12

562

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

154

2.80

8.97

1.2

1.3

ug/l

1134.6

55.1

1.14

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

592

4568

1.32

8.97

3.3

3.5

kpa

5.1

5.2

1.46

548

4178

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1350

11518

1.21

8.55

1.2

u/ml

1.4

1.9

1.18

336

2943

(3028626) Oxygen [Partial pressure] in Capillary blood

237

1576

1.52

8.47

2.8

kpa

8.0

7.8

0.41

222

1456

(3044007) Cell count panel - Peritoneal fluid

140

2.79

8.13

1.7

2.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

538

1.87

8.00

2.5

2.8

60.8

61.8

0.13

348

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

228

1524

1.51

7.98

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

228

1525

1.51

7.95

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

827

1.69

7.92

3.1

5.2

iu/ml

391.9

943.5

0.94

125

(3004119) Hemoglobin [Mass/volume] in Venous blood

586

4600

1.29

7.84

2.7

3.3

g/l

122.1

129.9

12.82

567

4475

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

264

2.24

7.79

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

264

2.24

7.79

1.3

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

497

3822

1.32

7.74

3.2

3.3

mmol/l

24.4

25.2

4.51

477

3703

(1761868) Lipid panel - Serum or Plasma

1599

18194

0.85

7.71

3.0

3.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

211

2.38

7.56

1.3

1.4

56.0

64.4

0.76

166

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

464

1.91

7.52

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

464

1.91

7.52

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

464

1.91

7.52

1.4

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

148

2.64

7.35

1.2

1.8

g/l

14.1

0.00

110

(3007164) IgA [Mass/volume] in Serum or Plasma

1134

9654

1.20

7.29

1.5

1.3

g/l

2.6

2.7

0.43

632

5348

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.38

7.23

2.4

1.3

u/l

64.1

45.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

354

2.01

7.14

1.8

2.0

u/field

2.8

2.4

0.22

236

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

625

1.75

7.13

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

253

1768

1.44

7.12

1.4

ug/g

240.9

280.0

2.28

160

1070

(3009261) Glucose [Presence] in Urine by Test strip

3378

31298

1.14

7.06

4.3

3.9

estimate

0.0

1.74

751

5106

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

511

1.83

7.02

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1512

13245

1.17

6.97

1.6

1.7

mg/l

2.0

1.3

6.10

1231

10249

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4362

46089

0.88

6.91

3.4

3.8

pmol/l

15.0

0.10

3816

40996

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3263

30194

1.13

6.91

2.1

pmol/l

88.1

93.7

9.67

1899

15572

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2579

23511

1.14

6.87

2.8

3.2

ng/l

1700.3

1731.4

0.11

2245

20367

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

471

6000

0.77

6.82

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1926

17213

1.16

6.81

4.5

4.3

estimate

0.0

0.48

677

5082

(3021601) Nitrite [Presence] in Urine by Test strip

3332

30897

1.13

6.79

5.6

5.2

estimate

0.0

0.31

761

5288

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

417

1.90

6.77

1.2

1.3

u/l

10.6

11.3

0.29

376

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

240

3379

0.70

6.77

1.3

au/ml

70.9

51.3

0.49

137

(3041096) Erythrocytes [Presence] in Urine by Automated

1759

15624

1.16

6.76

4.4

3.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5929

61387

0.87

6.67

4.7

5.1

mmol/l

6.2

6.1

2.63

5251

55029

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

185

1232

1.51

6.66

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

550

1.77

6.63

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

543

1.78

6.61

1.2

1.4

mmol/l

6.6

6.7

0.03

496

(3021901) Oxygen saturation in Capillary blood

201

1364

1.49

6.61

2.7

2.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

274

3744

0.72

6.48

2.4

au/ml

40.7

26.5

0.43

119

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

452

3522

1.30

6.44

2.3

2.6

1.2

0.48

446

3501

(3001893) Eosinophils/100 leukocytes in Pleural fluid

183

2.36

6.43

1.4

3.9

2.9

0.18

150

(3045142) Bone marrow Pathology biopsy report

454

1.84

6.40

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.05

6.34

2.4

2.3

17.0

10.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

129

2020

0.63

6.26

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

442

3448

1.30

6.25

2.2

2.6

0.7

0.07

427

3296

(4010399)

377

4885

0.76

6.22

1.4

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

297

2192

1.37

6.15

2.3

2.9

—

(3045788) Cell count panel - Pleural fluid

578

1.72

6.14

1.5

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

3321

30920

1.12

6.12

4.2

3.9

estimate

0.0

0.50

746

5230

(3035880) pH of Pleural fluid

333

1.96

6.12

1.2

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2019

22252

0.88

6.04

2.1

2.2

u/l

238.9

238.8

0.00

1899

20711

(3008898) HLA-B27 [Presence]

1307

0.55

6.03

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

840

7083

1.21

5.95

2.8

3.2

ng/l

240.9

246.2

0.13

764

6497

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

638

1.67

5.90

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

611

1.68

5.79

1.7

2.2

u/field

3.1

1.9

1.06

212

(3019977) pH of Arterial blood

429

1.80

5.64

2.9

2.3

7.4

0.91

158

(3008757) Leukocyte morphology finding [Identifier] in Blood

570

1.69

5.64

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1936

17516

1.14

5.58

1.6

nmol/l

20.5

20.2

0.33

1647

14749

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

146

2.40

5.52

1.3

1.4

25.3

27.2

0.13

118

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

574

0.36

5.51

1.0

ng/l

34.9

45.3

0.95

366

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

159

2.33

5.47

5.4

1.1

u/ml

38.2

137.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

571

0.37

5.45

1.0

ng/l

669.9

708.8

0.22

358

(1002224) Polysomnography panel

109

1714

0.63

5.44

1.1

—

(3022313) Gas panel - Capillary blood

411

3238

1.28

5.43

3.4

3.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

568

0.37

5.40

1.0

ng/l

246.4

334.2

2.63

370

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

357

2772

1.30

5.28

3.6

3.8

mmol/l

24.7

24.9

0.55

319

2515

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.00

5.25

1.1

1.0

—

(40758358) Immune stain study

+∞

5.21

1.0

0.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

225

1643

1.38

5.05

2.3

2.2

g/l

122.2

130.0

4.33

167

1216

(21494755) Public health laboratory ask at order entry panel

189

2623

0.71

4.99

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

109

1671

0.65

4.89

1.3

1.4

—

(4034850)

165

2328

0.70

4.82

14.0

10.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

124

817

1.53

4.81

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

498

1.67

4.76

1.3

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

2162

0.70

4.66

1.2

u/ml

3.6

0.8

0.70

212

(3005322) IgE [Units/volume] in Serum or Plasma

234

3105

0.75

4.65

1.2

1.3

u/ml

200.8

237.1

0.43

211

2863

(3020393) Adenovirus Ag [Presence] in Stool

3.21

4.60

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1228

0.61

4.52

1.1

1.2

mmol/l

3.9

0.02

1144

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

238

3134

0.75

4.50

1.8

1.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

471

1.66

4.39

1.6

1.3

—

(40765096) Chromosome analysis panel by Banding

2.62

4.38

1.1

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1216

0.61

4.36

1.3

1.4

e6/l

265.8

1570.6

1.95

1012

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1214

0.61

4.33

1.2

1.3

e6/l

10.4

23.3

0.87

958

(4094501)

125

1809

0.69

4.25

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

355

1.75

4.24

1.5

u/l

8.2

7.3

0.11

147

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

101

1522

0.66

4.23

1.4

1.7

mg/l

3.2

3.8

0.31

1086

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

175

2384

0.73

4.18

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

380

1.72

4.15

1.2

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

521

6192

0.83

4.07

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

880

0.57

4.03

4.2

umol/l

338.0

350.6

0.26

727

(3045424) Erythrocytes [Presence] in Urine

149

1058

1.42

4.03

1.8

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

311

1.77

3.95

1.7

1.5

u/l

133.7

1503.2

0.94

113

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.88

3.89

2.0

1.1

ug/l

3.1

2.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

485

0.43

3.84

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

584

1.55

3.83

1.9

1.7

—

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

186

1386

1.35

3.78

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

595

1.53

3.75

1.1

1.2

u/l

96.2

58.1

0.89

380

(3042631) Mycobacterium sp identified in Specimen

125

874

1.44

3.71

2.0

3.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

238

1.85

3.67

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

327

1.72

3.63

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

136

1881

0.72

3.62

1.3

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1632

17742

0.90

3.58

2.7

2.6

umol/l

3412.6

6277.7

2.57

1402

14949

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

329

1.71

3.56

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

304

2441

1.25

3.55

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

164

2.02

3.53

1.3

1.4

28.2

22.2

0.55

146

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

802

1.44

3.48

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

315

2547

1.25

3.47

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

422

0.43

3.46

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

128

913

1.41

3.43

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

242

1901

1.28

3.41

2.9

3.1

mmol/l

24.1

24.9

1.58

213

1674

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5509

56597

0.92

3.33

4.2

4.6

mu/l

2.7

2.1

0.66

4828

50721

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

2.26

3.28

1.9

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

172

1299

1.33

3.25

1.5

1.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.74

3.23

1.0

1.1

nmol/l

195.6

264.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

122

1678

0.72

3.19

1.3

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.47

3.12

1.2

1.3

u/l

36.0

479.8

0.48

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

391

1.59

3.06

1.4

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

318

2614

1.22

3.05

2.0

2.3

ug/l

389.5

701.0

2.13

310

2466

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

228

0.35

3.03

1.1

1.8

ug/l

24.7

173.9

—

210

(3000012) Reticulocyte production index

401

1.57

2.99

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

174

1334

1.31

2.99

1.0

1.1

u/ml

5.3

11.8

0.73

100

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

105

1462

0.71

2.98

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

900

1.37

2.90

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

192

1499

1.29

2.89

1.7

3.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

126

1695

0.74

2.89

1.5

1.6

iu/ml

4.0

3.8

0.01

392

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

206

1.80

2.89

1.8

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

221

1.77

2.88

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

304

1.65

2.87

1.1

u/l

82.2

87.9

0.21

229

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

110

1506

0.73

2.84

1.6

1.8

nmol/l

41.6

44.8

0.88

104

1428

(3019150) Specific gravity of Urine by Refractometry

1332

14463

0.91

2.81

4.4

kg/l

1.0

0.00

219

2254

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.22

2.79

1.4

14.3

7.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

180

1.84

2.76

1.5

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

556

4852

1.16

2.73

2.3

1.8

nmol/l

402.5

368.4

3.36

517

4347

(3014271) Vancomycin [Susceptibility]

484

1.49

2.71

3.0

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

116

854

1.36

2.66

1.6

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

303

1.62

2.66

1.1

u/l

31.7

24.3

0.36

217

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.55

2.61

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1040

1.32

2.58

1.2

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.11

2.48

1.1

1.2

ng/l

103.9

156.6

—

(3022475) Manganese [Moles/volume] in Blood

4.38

2.47

1.7

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

270

0.41

2.46

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

279

1.62

2.44

1.1

5.6

mg/l

55.9

82.0

1.46

190

(3003181) Sodium [Moles/volume] in Urine

161

1260

1.28

2.44

1.4

1.3

mmol/l

58.4

63.8

0.84

112

1017

(3006922) Hepatitis E virus Ab [Presence] in Serum

303

1.59

2.43

1.1

—

(44806118)

613

1.41

2.42

1.2

1.4

—

(44790048)

614

1.40

2.40

1.2

1.4

—

(44790047)

614

1.40

2.40

1.2

1.4

—

(44790049)

614

1.40

2.40

1.2

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

1.97

2.39

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

153

1.83

2.37

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

904

0.68

2.36

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

369

1.52

2.36

2.1

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

1119

1.29

2.32

3.1

3.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

593

1.40

2.32

2.2

1.9

—

0.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

283

1.59

2.32

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

283

1.59

2.32

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

428

1.48

2.30

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1694

15876

1.08

2.29

1.7

pmol/l

6214312.5

27707210.3

2.34

1384

12755

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

261

0.42

2.29

1.1

—

(3042733) HLA Ab [Presence] in Serum

155

0.32

2.27

2.2

5.0

—

(3017569) Oxygen content in Arterial blood

381

1.50

2.26

2.1

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2971

28449

1.07

2.24

4.9

4.0

ug/l

3.3

2.6

1.11

2583

25345

(1761482) Bacteria [#/volume] in Urine by Culture

247

2056

1.21

2.19

4.8

4.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

147

1855

0.79

2.18

1.6

1.5

e6/l

16036.5

14332.5

0.19

109

1334

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.33

2.17

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

180

0.39

2.14

39.3

34.0

ug/l

6.3

7.4

—

165

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

386

1.48

2.14

2.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

123

1.87

2.10

1.8

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

357

0.53

2.08

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

221

1.63

2.08

1.6

1.9

15.1

17.3

0.27

(1001926) Buprenorphine [Presence] in Urine by Screen method

418

0.57

2.03

1.1

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

131

1026

1.28

2.03

2.7

2.3

—

(3045414) Leukocytes [Presence] in Urine

336

2895

1.17

2.03

2.2

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

177

0.39

2.02

1.0

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2678

25629

1.07

2.01

2.2

nmol/l

76.3

79.0

4.90

2367

22205

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2497

23845

1.07

2.00

4.6

4.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

827

1.31

1.99

1.2

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

271

0.48

1.97

1.0

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

156

1.73

1.95

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

400

0.57

1.95

1.3

1.4

pmol/l

107.6

146.9

—

116

(3011412) CD3 cells [#/volume] in Blood

297

1.52

1.94

1.6

1.8

e9/l

1.3

1.0

0.47

173

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

547

0.64

1.93

1.1

—

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.96

1.93

1.0

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.73

1.93

2.1

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.73

1.93

7.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

282

0.50

1.92

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.05

1.90

1.3

mmol/l

0.9

1.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.98

1.84

1.4

1.2

ug/l

44.4

124.2

5.49

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

261

1.53

1.83

1.1

1.3

—

(44813793)

341

0.56

1.82

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

183

0.44

1.80

3.3

6.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

122

1532

0.79

1.80

1.2

u/ml

50.0

44.5

—

(3008037) Lactate [Moles/volume] in Venous blood

213

1789

1.20

1.78

3.3

mmol/l

1.7

0.42

208

1741

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

737

1.31

1.77

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

530

1.36

1.77

1.0

1.1

u/ml

6.7

4.0

0.27

181

(3044290) Cell count panel - Cerebral spinal fluid

1077

0.76

1.73

1.2

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

231

0.48

1.73

1.0

1.1

u/ml

—

8.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

447

0.62

1.73

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

347

0.58

1.72

1.1

2.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

155

1.68

1.71

1.5

1.4

—

(3000492) Spirometry study

455

5087

0.89

1.71

1.4

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1199

0.77

1.71

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

3.85

1.71

2.4

1.5

ng/l

232.4

207.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.70

0.0

1.1

—

(3027008) Opiates [Presence] in Urine

541

0.66

1.69

1.1

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1139

0.77

1.68

1.6

—

(3020491) Glucose [Moles/volume] in Blood

479

0.65

1.67

1.8

2.3

mmol/l

8.3

7.1

0.86

324

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.16

1.66

3.2

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.16

1.66

6.3

5.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.58

1.65

4.1

2.6

—

(3017732) Neutrophils [#/volume] in Blood

450

4024

1.12

1.64

4.0

3.0

e9/l

3.9

4.1

0.92

336

2840

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

525

0.66

1.64

1.1

—

48.8

—

(3016879) Cocaine [Presence] in Urine

512

0.66

1.63

1.1

1.8

—

(21494434) Karyotype in Bone marrow

488

1.35

1.60

1.1

—

(3028300) Cannabinoids [Presence] in Urine

545

0.68

1.59

1.1

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.06

1.59

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.00

1.58

1.5

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

136

1.69

1.58

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

412

3675

1.13

1.58

2.0

2.2

nmol/l

10.3

14.7

18.89

351

3177

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

171

0.47

1.57

1.0

1.2

—

32.2

—

(4027681)

222

0.49

1.57

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

577

5248

1.11

1.56

1.3

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

904

1.25

1.55

1.8

2.3

mg/l

33.1

27.3

0.25

224

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

659

0.71

1.55

1.3

1.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.11

1.54

1.6

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

1435

0.81

1.54

1.2

u/ml

2.3

5.1

2.65

233

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

1420

0.81

1.51

1.2

u/ml

9.4

7.0

0.19

151

(3000764) Benzodiazepines [Presence] in Urine

538

0.69

1.50

1.1

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

1.49

0.0

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

192

1628

1.18

1.49

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

560

0.69

1.48

1.1

u/ml

1.2

1.3

0.06

221

(3002619) Bacteria identified in Specimen by Culture

116

1.73

1.48

1.5

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

173

1455

1.19

1.48

2.7

mg/l

1.9

1.8

0.66

155

1272

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

721

0.73

1.47

1.5

29.9

28.7

0.08

464

(3004451) EKG impression Narrative

376

1.38

1.47

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1138

0.79

1.46

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

445

1.35

1.45

1.3

1.8

umol/l

86.8

70.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1214

0.80

1.45

1.2

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

366

0.63

1.45

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

215

0.51

1.44

1.5

1.3

—

(3027944) Amphetamines [Presence] in Urine

532

0.69

1.43

1.1

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

227

0.53

1.43

1.0

1.1

u/l

4.1

1.0

—

104

(3036670) Protein [Mass/volume] in Synovial fluid

265

0.57

1.42

1.2

g/l

40.4

39.9

—

132

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

1790

0.83

1.41

1.4

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

229

1.49

1.40

3.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

229

1.49

1.40

3.7

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

100

801

1.25

1.39

1.3

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.41

1.39

1.0

1.1

36.4

36.3

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.41

1.39

1.0

1.1

21.7

22.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.41

1.39

1.0

1.1

8.7

9.1

—

(3021788) Differential panel - Synovial fluid

110

1348

0.81

1.37

1.4

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.94

1.36

5.4

3.9

umol/l

0.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.94

1.36

1.6

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

467

0.68

1.35

1.0

1.1

u/ml

1.1

0.8

0.23

182

(3015736) pH of Urine

2529

24407

1.05

1.35

3.8

3.7

5.7

5.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.75

1.34

2.7

u/field

0.8

0.5

0.59

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

1264

0.81

1.31

1.2

—

14.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

179

2083

0.86

1.28

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2313

23944

0.95

1.24

4.2

4.0

mg/mmol

11.2

9.1

1.16

1521

15268

(3003888) Timothy IgE Ab [Units/volume] in Serum

481

0.71

1.24

1.0

1.1

u/ml

1.5

3.1

1.03

218

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

256

2893

0.88

1.23

1.1

1.2

iu/ml

140.2

121.7

0.31

1041

(3027456) Digoxin [Moles/volume] in Serum or Plasma

214

1868

1.15

1.21

3.1

nmol/l

0.8

0.06

161

1454

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

141

0.50

1.20

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

409

1.32

1.19

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

414

3765

1.10

1.19

2.6

2.2

g/l

9.9

10.9

3.72

372

3415

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

274

0.62

1.17

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

381

0.68

1.16

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

380

0.68

1.15

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

380

0.68

1.15

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

701

0.77

1.14

1.1

1.2

miu/ml

178.8

202.1

0.13

253

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

2057

1.14

1.13

1.6

—

(3044941) Cell count panel - Synovial fluid

1174

0.82

1.12

1.4

—

(36660697) Celiac disease serology panel - Serum

457

4191

1.10

1.12

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

377

0.69

1.11

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

377

0.69

1.11

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.26

1.10

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

741

0.78

1.10

1.6

1.3

e6/l

54216.9

188499.1

2.62

506

(40759836) Histone Ab [Presence] in Serum by Immunoblot

376

0.69

1.09

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.82

1.08

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

193

0.57

1.07

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

193

0.57

1.07

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

193

0.57

1.07

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

193

0.57

1.07

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.12

1.05

2.3

1.1

—

(4146454)

107

896

1.20

1.04

2.9

2.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

331

3001

1.11

1.04

2.1

1.4

g/l

1.5

1.2

0.74

299

2697

(3024263) Appearance of Synovial fluid

383

0.70

1.04

1.7

1.5

—

(3048879) Bone marrow aspiration report

162

1.48

1.03

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

532

0.75

1.03

1.3

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

280

1.36

1.03

1.4

1.3

u/l

39.5

34.9

0.30

192

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

178

0.56

1.03

1.0

1.1

miu/ml

1571.5

1747.3

—

178

(3014891) Appearance of Pleural fluid

114

1.58

1.02

1.9

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

1.56

1.02

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

125

1460

0.85

1.00

1.5

1.7

—

(3011648) Oxygen content in Venous blood

502

1.26

0.99

1.3

2.0

11.0

11.1

0.01

502

(3024932) HLA-DR beta [Type]

133

0.53

0.98

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

802

1.20

0.97

1.1

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

2221

22891

0.96

0.97

3.3

3.2

mmol/l

7.4

7.3

0.25

1818

18998

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1914

0.87

0.97

2.7

1.5

g/l

0.0

0.00

150

1739

(3016650) Hepatitis A virus Ab [Presence] in Serum

713

1.21

0.95

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.95

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

282

0.67

0.94

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

622

5826

1.07

0.94

2.5

1.6

g/l

65.0

66.6

4.88

549

5138

(3000093) Morphology [Interpretation] in Blood Narrative

614

1.22

0.94

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.89

0.94

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2194

22603

0.96

0.94

3.3

3.2

mg/l

248.4

307.6

0.36

1489

14500

(3028679) Herpes simplex virus Ab [Presence] in Serum

209

0.62

0.93

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

103

871

1.18

0.93

8.9

15.4

mmol/l

6.7

7.4

2.77

714

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

144

0.55

0.93

5.1

7.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

331

1.30

0.90

2.5

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.60

0.90

1.1

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

110

1.55

0.90

1.3

1.2

mmol/l

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

971

0.83

0.90

1.6

1.5

65.7

61.9

0.38

615

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

838

0.82

0.88

1.4

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

114

978

1.17

0.88

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

358

0.73

0.87

1.1

nmol/l

0.6

7.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

333

1.29

0.87

1.1

1.2

u/l

125.7

86.4

0.90

283

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

220

1.36

0.87

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

275

3019

0.91

0.86

1.5

u/ml

29.4

16.9

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

522

1.23

0.85

1.1

1.2

95.7

93.5

0.28

489

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

167

0.60

0.84

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

790

0.82

0.84

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

388

1.26

0.84

2.1

ug/min

48.7

182.2

1.46

102

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.87

0.81

1.0

—

(3036603) Volume of Urine

390

1.26

0.81

1.7

1.4

1802.7

1975.9

0.41

(3035320) C reactive protein [Mass/volume] in Body fluid

417

1.25

0.81

2.5

2.7

—

(3006462) Nitrate [Presence] in Urine

328

1.28

0.81

4.8

3.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

189

0.63

0.81

1.0

1.1

81.4

95.2

—

146

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

675

0.81

0.80

1.7

u/ml

28.9

25.6

—

157

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

188

0.64

0.79

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

837

0.83

0.78

1.9

mu/l

260.7

302.5

0.79

766

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.9

—

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

702

1.18

0.78

1.2

1.4

u/ml

99.5

120.9

1.07

144

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

115

999

1.15

0.78

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

123

0.57

0.77

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

540

0.79

0.77

1.3

—

(3000285) Sodium [Moles/volume] in Blood

124

0.56

0.77

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

124

0.56

0.77

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

104

1201

0.86

0.77

1.7

iu/l

7.7

4.3

0.84

361

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.77

0.0

9.9

—

184.9

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.77

0.0

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

650

0.81

0.77

1.1

1.2

mmol/l

7.6

7.8

0.10

444

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

572

0.80

0.76

1.3

titre

116.0

486.4

—

(3046861) Legionella sp Ag [Presence] in Urine

1.76

0.76

1.3

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

323

1.27

0.75

1.1

1.2

u/l

52.1

22.0

0.98

270

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

180

2001

0.90

0.75

2.3

ug/min

152.1

117.4

0.34

102

1182

(3024471) HLA-A [Type]

136

0.59

0.72

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

0.72

1.8

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

356

0.76

0.72

1.4

1.5

2.1

4.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

188

1697

1.11

0.71

2.6

1.5

—

(3003129) Base excess in Capillary blood by calculation

206

0.68

0.71

1.3

1.7

mmol/l

-0.1

0.6

0.62

197

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.92

0.70

1.2

1.4

6.5

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1094

0.87

0.70

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

244

2235

1.09

0.70

1.1

titre

108.0

201.5

—

(4211845)

363

1.24

0.70

4.6

3.2

—

(3000034) Microalbumin [Mass/volume] in Urine

730

1.17

0.69

3.4

3.0

mg/l

61.1

40.6

0.29

541

(3029075) Extractable nuclear Ab panel - Serum

146

0.62

0.69

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

713

1.17

0.68

1.3

nmol/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

146

1630

0.89

0.68

1.3

1.5

g/l

0.2

0.64

138

1536

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

121

0.58

0.67

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.66

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

223

1.30

0.66

1.4

1.8

e6/l

413.3

688.9

—

(4133840)

128

1.41

0.65

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

177

1950

0.91

0.65

2.7

1.5

g/l

0.0

0.69

151

1745

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

717

1.16

0.64

1.2

u/ml

5.1

4.2

0.14

229

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

771

7376

1.05

0.64

2.2

2.5

ug/l

5.1

7.7

4.85

651

6308

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.72

0.64

2.4

2.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.49

0.63

1.1

1.2

—

(4015189)

234

0.73

0.62

1.8

2.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

164

1.34

0.62

2.2

2.7

mmol/l

7.7

7.8

0.04

104

(4198724)

102

0.59

0.62

1.0

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.61

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

702

1.15

0.61

1.2

u/ml

2.4

4.5

2.71

316

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3000330) Specific gravity of Urine by Test strip

401

3776

1.06

0.59

5.3

3.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

243

0.74

0.59

1.2

1.4

—

(3023410) Appearance of Cerebral spinal fluid

487

0.82

0.59

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

157

1.34

0.58

2.0

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.44

0.58

2.0

1.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

197

0.71

0.58

1.4

1.2

g/l

—

0.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

9.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.51

0.58

1.1

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

584

0.84

0.58

1.9

ug/l

3.9

3.7

0.07

520

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

1199

0.89

0.56

1.1

1.2

u/ml

5.4

7.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

420

1.19

0.56

1.1

—

(3025130) Human papilloma virus identified in Specimen

329

1.22

0.55

1.5

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

662

1.15

0.55

2.1

1.3

—

(3006270) Folate [Moles/volume] in Blood

681

1.15

0.55

1.2

nmol/l

324.7

335.5

0.17

531

(3006576) Bicarbonate [Moles/volume] in Blood

293

1.23

0.55

5.7

6.4

mmol/l

25.3

25.0

0.19

266

(3002523) Influenza virus A Ag [Presence] in Specimen

421

1.19

0.55

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

168

1.31

0.54

1.1

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

122

0.66

0.54

1.5

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.41

0.54

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.48

0.53

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

404

1.19

0.53

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

749

1.14

0.53

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

250

2328

1.08

0.53

2.7

1.5

mg/l

40.1

37.9

0.21

210

1847

(3014133) Dog dander IgE Ab [Units/volume] in Serum

349

0.80

0.52

1.0

1.1

u/ml

4.1

3.0

—

143

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.52

1.0

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

250

2333

1.07

0.51

2.7

1.5

mg/l

62.2

48.7

1.10

211

1858

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

686

1.14

0.51

4.1

3.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

214

0.75

0.51

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

397

1.18

0.51

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

398

1.18

0.50

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

297

1.21

0.50

1.3

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

101

1.39

0.49

1.2

1.8

22.9

26.3

0.43

(3028433) Virus identified in Specimen by Culture

181

1.27

0.47

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

891

9200

0.96

0.47

11.7

7.7

—

(3025577) Chromium [Mass/volume] in Blood

570

0.86

0.47

2.0

ug/l

2.0

2.2

0.34

469

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

617

1.14

0.46

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

817

1.11

0.45

1.3

1.2

nmol/l

0.6

3.8

0.99

783

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

241

2261

1.07

0.44

2.7

1.5

ratio

1.4

2.1

1.08

181

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

174

1.26

0.44

2.2

2.4

39.4

41.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

438

0.84

0.44

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.37

0.44

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

194

2078

0.93

0.43

2.7

1.5

g/l

0.2

0.0

0.45

168

1867

(3023511) Choriogonadotropin [Units/volume] in Urine

127

0.71

0.43

1.1

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

154

1664

0.92

0.43

1.3

1.5

g/l

1.2

0.27

145

1564

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.61

0.43

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

145

1570

0.92

0.43

3.7

3.6

mg/l

33.0

27.9

0.74

1042

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.41

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

440.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1575

15421

1.03

0.41

3.6

3.9

—

(4212803)

1.36

0.41

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

114

1.32

0.40

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

216

0.79

0.40

1.0

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

1.28

0.40

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.36

0.40

2.0

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.36

0.40

2.0

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

400

0.85

0.39

1.0

1.1

u/ml

2.4

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

171

0.76

0.39

6.0

7.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

105

0.67

0.39

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

137

0.73

0.39

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

209

2221

0.94

0.39

2.5

1.4

g/l

36.9

37.3

0.41

158

1847

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

693

1.11

0.38

1.1

1.2

u/ml

298.8

294.6

0.04

436

(3014051) Protein [Presence] in Urine by Test strip

164

1529

1.07

0.38

2.6

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

632

0.88

0.38

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

473

0.87

0.38

1.1

1.2

titre

90.0

155.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.34

0.38

10.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

215

1.21

0.38

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

112

0.71

0.37

1.0

1.2

—

320.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

543

5239

1.04

0.37

3.4

3.8

ng/l

100.4

98.2

0.20

468

4383

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3002

29648

1.02

0.36

2.2

2.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.29

0.36

6.6

5.0

ug/min

59.1

46.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.29

0.36

2.1

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.62

0.35

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.40

0.35

1.5

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.40

0.35

1.5

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.40

0.35

1.5

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.33

0.33

2.5

3.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

209

1.20

0.33

1.2

1.7

e6/l

520.2

426.5

0.49

179

(4268621)

481

1.12

0.33

2.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

232

0.82

0.33

1.5

1.9

umol/l

117.8

129.8

—

128

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

223

2350

0.95

0.33

1.6

titre

153.3

304.1

—

119

(40757373) Influenza virus identified in Isolate

144

0.76

0.33

1.3

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.30

0.33

1.0

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.70

0.33

1.2

1.5

73.8

71.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.32

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

101

1.29

0.31

1.2

1.9

23.3

8.4

1.32

(3044927) Protein electrophoresis panel - Urine

848

1.09

0.31

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.73

0.30

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

1140

0.93

0.30

1.2

u/l

40.9

27.1

0.75

969

(3028717) Thiamine [Mass/volume] in Blood

1.30

0.30

1.0

1.1

—

(4062490)

557

0.90

0.30

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.29

0.29

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.29

0.29

1.2

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

2666

0.95

0.29

2.3

1.4

g/l

10.1

10.4

0.42

198

2192

(3010838) Calcium [Moles/time] in 24 hour Urine

314

0.86

0.29

1.3

1.7

—

6.5

—

(3045716) Anion gap in Serum or Plasma

372

1.13

0.29

2.9

2.2

mmol/l

9.4

9.1

0.19

272

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.29

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.23

0.29

1.3

1.4

pmol/l

12.9

57.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

747

1.08

0.28

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.28

0.28

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.28

0.28

1.2

1.4

—

(4024509)

700

1.09

0.27

1.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

605

0.91

0.27

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

187

1.18

0.26

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

800

0.92

0.25

1.1

1.4

—

(3017704) Immunofixation for Urine

396

1.11

0.25

1.4

1.2

—

(3008295) Osmolality of Serum or Plasma

598

1.09

0.25

1.2

1.4

mosm/kgh2o

273.2

276.4

0.69

443

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.24

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

142

1.20

0.24

1.4

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

255

0.86

0.24

2.9

2.2

umol/l

53.1

59.2

0.51

201

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

138

1307

1.06

0.24

1.4

nmol/l

0.8

0.41

116

1074

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

318

0.88

0.24

2.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.71

0.24

1.2

1.5

mu/l

5492.3

719.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

668

1.08

0.23

1.1

1.2

111.0

114.9

0.54

599

(3022621) pH of Urine by Test strip

467

4546

1.03

0.23

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

290

2999

0.97

0.23

3.0

2.9

pmol/l

4.3

4.4

1.66

258

2584

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

168

0.83

0.22

1.1

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

556

0.92

0.22

1.3

1.4

g/l

2.7

3.0

0.50

388

(3024139) IgG subclass 3 [Mass/volume] in Serum

556

0.92

0.22

1.3

1.4

g/l

0.4

0.81

391

(3027135) IgG subclass 1 [Mass/volume] in Serum

556

0.92

0.22

1.3

1.4

g/l

6.4

6.9

0.40

387

(3005033) Fetal Nuchal fold Thickness US

1.27

0.22

1.2

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

115

1214

0.95

0.22

1.1

1.3

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

175.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

558

5454

1.02

0.21

1.5

1.7

1.6

0.14

473

4585

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

154

1.17

0.21

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

227

2352

0.96

0.20

2.5

1.5

g/l

0.8

0.5

0.72

183

1968

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

553

0.92

0.20

1.2

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.25

0.20

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

861

0.94

0.20

1.5

1.6

g/l

1.0

0.9

0.20

650

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

113

0.80

0.20

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

231

1.13

0.19

1.8

1.3

umol/l

13.5

9.3

0.36

157

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.18

0.19

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.22

0.19

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

149

1428

1.04

0.19

1.6

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.13

0.18

1.5

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.23

0.18

1.9

1.6

umol/l

47.4

45.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.23

0.18

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

137

1.17

0.18

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

311

0.90

0.18

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

0.85

0.18

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

204

1.13

0.18

1.3

29.9

34.0

0.22

128

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

1479

0.96

0.17

1.8

1.9

mg/l

11.4

11.8

0.18

132

1358

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.21

0.17

2.2

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

329

1.09

0.17

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

157

1.15

0.17

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.13

0.17

1.4

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.76

0.17

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

233

2400

0.97

0.17

1.8

u/l

38.5

38.2

0.09

207

2022

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.73

0.17

2.2

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

319

0.91

0.16

1.0

1.1

u/ml

3.2

3.1

—

126

(3020191) Ethanol [Moles/volume] in Serum or Plasma

443

0.92

0.16

1.1

1.3

promille

1.2

0.02

334

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.16

1.1

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

292

1.10

0.16

1.0

1.1

nmol/l

125.2

139.5

0.60

292

(4306422)

690

1.06

0.16

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

863

0.95

0.16

1.2

1.1

iu/ml

9661.4

1266.5

0.41

166

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.11

0.16

3.5

2.6

—

30.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

380

0.92

0.15

1.2

1.3

u/ml

0.1

1.2

2.27

208

(40768443) Skin Pathology biopsy report

262

2551

1.03

0.15

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.20

0.15

1.3

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.12

0.15

2.3

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.15

1.3

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

782

1.05

0.14

1.1

1.3

pmol/l

258.0

272.5

0.21

589

(3023323) Follitropin [Units/volume] in Serum or Plasma

773

1.05

0.13

1.2

1.3

iu/l

39.4

33.5

0.76

657

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

103

1.16

0.13

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

283

0.92

0.12

1.1

1.2

mmol/l

6.2

0.06

265

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

142

1.13

0.12

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

148

0.88

0.12

1.5

1.6

ng/l

160.5

128.4

0.21

148

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

262

0.92

0.12

1.4

nmol/l

0.4

0.2

0.28

200

(3001964) Herpes simplex virus Ag [Presence] in Specimen

152

1.12

0.12

1.1

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

855

1.04

0.12

1.3

u/l

18.1

8.9

4.25

671

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

199

0.90

0.11

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

288

1.08

0.11

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

327

1.07

0.11

1.4

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

147

0.88

0.11

1.5

1.9

mmol/l

1.2

0.20

142

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

425

1.06

0.11

1.3

1.2

mmol/l

11.1

12.0

0.42

127

(3004588) Protein electrophoresis panel - Serum or Plasma

511

5039

1.01

0.11

2.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.15

0.10

1.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

251

1.08

0.10

1.4

1.1

—

(3003338) MCHC [Mass/volume]

4964

49741

0.99

0.09

40.4

19.5

g/l

329.2

332.0

77.70

4922

49235

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

359

1.06

0.09

3.6

4.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

176

0.91

0.09

1.2

—

(3011985) Renin [Units/volume] in Plasma

832

1.03

0.09

1.2

1.3

mu/l

68.7

59.6

0.16

739

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.07

0.08

1.5

1.2

umol/24h

1.4

1.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.07

0.08

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

243

1.07

0.08

4.8

5.7

65.5

71.7

0.54

205

(3005011) Chlamydia sp Ab [Titer] in Serum

1.05

0.08

1.7

1.8

—

(44806420)

253

1.07

0.08

2.6

2.4

—

(3034426) Prothrombin time (PT)

175

1.09

0.08

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.81

0.08

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

371

1.05

0.08

1.2

1.3

nmol/l

1.4

1.2

0.44

277

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

870

8635

1.01

0.07

4.3

5.0

33.0

33.1

0.11

557

5729

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

2838

0.99

0.07

2.3

1.4

g/l

3.7

3.9

0.89

183

1985

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.07

0.07

1.3

1.6

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.89

0.06

1.1

1.6

—

7.9

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.85

0.06

12.6

11.3

mmol/l

7.4

5.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

2843

0.99

0.06

2.3

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

105

0.86

0.06

1.1

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

148

1.08

0.06

2.0

3.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

162

0.93

0.06

1.5

ug/l

10.6

9.2

0.81

162

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

2648

1.01

0.06

2.4

1.4

g/l

3.2

3.1

0.68

190

2026

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

247

1.05

0.05

1.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

827

0.98

0.05

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

282

2846

0.99

0.04

2.3

1.4

g/l

7.6

7.5

0.55

198

2056

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2286

22795

1.00

0.04

4.3

3.9

21.7

24.4

14.92

1173

11458

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

541

5377

1.01

0.04

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

756

1.02

0.03

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.06

0.02

1.0

1.1

90.8

83.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

1.03

0.02

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

152

1.05

0.02

1.1

1.3

—

1615592.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

610

0.98

0.02

1.3

nmol/l

1.2

1.5

1.25

550

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

189

1902

0.99

0.02

1.3

1.4

iu/ml

18.5

18.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

700

1.01

0.02

1.1

—

(3023419) Bacteria identified in Sputum by Culture

900

0.99

0.02

3.1

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

103

1.07

0.02

1.2

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1577

15743

1.00

0.02

3.1

2.8

ug/l

0.8

0.7

1.02

1108

11105

(3001186) Copper [Moles/volume] in Serum or Plasma

113

1.06

0.01

1.2

1.1

umol/l

18.1

15.8

1.98

104

(3051593) INR in Capillary blood by Coagulation assay

423

1.02

0.01

8.6

11.0

—

(40761535) Cells panel - Urine sediment

605

6058

1.00

0.01

3.5

3.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

0.96

0.00

1.0

1.1

86.4

84.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

134

1.04

0.00

1.2

1.1

umol/24h

0.7

0.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

153

0.98

0.00

1.1

—

(3004775) Volume in Urine collected for unspecified duration

657

1.00

0.00

2.0

2.3

747.0

643.4

0.88

447

(40768446) Kidney Pathology biopsy report

198

1.01

0.00

1.5

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

197

1.01

0.00

5.9

7.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.01

0.00

1.0

1.2

114.1

107.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

187

1.02

0.00

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

155

1.03

0.00

1.1

—

(3016750) Collection duration of Urine

445

0.99

0.00

2.3

2.1

min

497.5

501.1

0.08

337

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

849

1.00

0.00

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

399

3989

1.00

0.00

1.2

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

225

1.02

0.00

2.0

ug/l

68.3

49.2

1.14

218

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

300

1.00

0.00

1.1

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

218

2178

1.00

0.00

1.1

u/ml

2.4

8.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

147

1.02

0.00

1.1

1.2

pmol/l

298.7

278.0

0.09

101

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

1.01

0.00

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

183

0.98

0.00

1.1

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

270

1.00

0.00

1.3

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.3

—

0.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.00

0.00

1.4

1.3

—

249.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

0.00

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

0.00

1.0

1.1

u/l

8.2

9.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.85

0.00

1.4

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

4.6

—

65.9

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.00

0.00

2.9

4.5

—

(3007916) DNA double strand Ab [Titer] in Serum

0.90

0.00

1.0

1.2

—

76.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.02

0.00

1.0

1.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

343.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(44806071)

0.89

0.00

1.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

134.8

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.92

0.00

1.1

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1346.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.93

0.00

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.01

0.00

1.0

1.5

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.95

0.00

1.3

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

0.98

0.00

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

11.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

2.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(4038314)

0.00

0.0

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.8

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_COLORECTAL_ADENO_EXALLC – Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

GWS hits: 23

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) (C3_COLORECTAL_ADENO_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints